Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Male dogs more likely to develop contagious oro-nasal cancer
"We think it's important to consider CTVT as a possible diagnosis for oro-nasal tumours in dogs" - Dr Andrea Strakova.
Researchers believe this may be due to behavioural differences.

Male dogs are four to five times more likely to develop a contagious cancer on their nose and mouth than female dogs, a study from the University of Cambridge has found.

Canine Transmissible Venereal Tumour (CTVT) is spread when dogs come into contact. An infectious cancer, the living cancer cells are able to transplant from one dog into another.

CTVT affects the genitalia of dogs most commonly, and is often transmitted during mating, however, the cancer can also affect a dog's nose, mouth and skin. The oro-nasal form of CTVT is transmitted through the sniffing or licking dogs' genitalia.

Dr Andrea Strakova, first author of the paper, explained: “We found that a very significant proportion of the nose or mouth tumours of canine transmissible cancer were in male dogs.

“We think this is because male dogs may have a preference for sniffing or licking the female genitalia, compared to vice versa. 

“The female genital tumours may also be more accessible for sniffing and licking, compared to the male genital tumours.”

In the study, researchers reviewed a database of almost 2,000 CTVT cases worldwide, finding that only 32 cases affected the nose and mouth. Of these cases, 27 were male dogs.

Dr Strakova discussed the importance of veterinary surgeons being aware of oro-nasal CTVT:
“Although canine transmissible cancer can be diagnosed and treated fairly easily, veterinarians in the UK may not be familiar with the signs of the disease because it is very rare here.

“We think it’s important to consider CTVT as a possible diagnosis for oro-nasal tumours in dogs. Treatment is very effective, using single agent Vincristine chemotherapy, and the vast majority of dogs recover.”

Signs of the oro-nasal form of CTVT include sneezing, snoring, difficulty breathing, nasal deformation or bloody or other discharge from the nose or mouth.

Published in Veterinary Record, 'Sex disparity in oronasal presentations of canine transmissible venereal tumour' is available to read here. 

Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
APHA launches free virtual work experience programme

The Animal and Plant Health Agency (APHA), in collaboration with Springpod, has launched a free virtual work experience programme, giving young people across the UK the chance to explore careers dedicated to protecting animal and plant health.

The on-demand programme offers a unique insight into career opportunities within APHA, showcasing how students can contribute to tackling some of the UK's most critical biosecurity and environmental challenges.

Designed for students aged 13 and over, the course includes more than 10 hours of engaging content featuring real-life industry insights, scenario-based challenges, and practical guidance on applying for jobs. To register for the course, visit the APHA website.